Yahoo Web Search

Search results

1. • Flu Breakthrough: Vanderbilt Scientists Discover Powerful New Weapon

     SciTechDaily· 9 hours ago

     Vanderbilt University researchers have identified potent monoclonal antibodies against influenza B, showcasing a promising avenue for treatment and preventative strategies ...

2. • Researchers take step toward development of universal COVID-19 antibodies

     Valley City Times Record· 7 days ago

     SARS-CoV-2, the virus that causes COVID-19 disease, continues to evolve and evade current vaccine and therapeutic interventions. A consortium of scientists at Texas Biomedical ...

3. • 

     House Republicans’ Attempts to Attack Fauci Go Wildly Off Rails

     The New Republic via Yahoo News· 3 days ago

     “No—I’m on the record, and I want to make sure that this is clear: that I developed a monoclonal ...

4. • 

     mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications

     Clinical Trials Arena via Yahoo Finance· 3 hours ago

     The RSV market has altered substantially in recent years owing to the emergence of novel vaccines...

5. • 

     Fauci Testimony Turns Chaotic: 'Most Insane Hearing I've Attended'

     Rolling Stone· 3 days ago

     Anthony Fauci over his involvement in the response to the Covid-19 pandemic. Fauci was summoned...

6. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

     Roanoke-Chowan News-Herald· 6 days ago

     Food and Drug Administration (FDA) on an expedient, repeatable immunobridging pathway to future potential emergency use authorizations (EUAs) for serial, novel monoclonal ...

7. • On a congressional COVID hearing, and weaponized uncertainty

     Columbia Journalism Review· 8 hours ago

     As the virus continued to spread, so did various versions of the theory. In February 2021, Facebook finally announced that it would remove any posts suggesting that the COVID

8. • 

     A Guide to Managing Covid This Summer

     New York Times· 3 days ago

     KP.2, one of these variants, now accounts for 28.5 percent of cases, and data from the Centers for Disease Control and Prevention shows a small increase...

9. • 

     Invivyd aligns with FDA on rapid mAb trial pathway By Investing.com

     Investing.com· 6 days ago

     Food and Drug Administration (FDA) on a new clinical trial pathway for the expedited development of ...

10. • MS Med Nearly Eliminates Disease Activity on MRI

      Medscape· 1 day ago

      A second-generation anti-CD40L monoclonal antibody suppresses multiple sclerosis (MS) disease activity on MRI to an uncommonly high degree, new trial data ...